NCT01367496View on ClinicalTrials.gov

Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions

Healthy Subjects

Interventions

DRUG

SC Methylnaltrexone (MNTX)

Dose 1

DRUG

SC Methylnaltrexone (MNTX)

Dose 2

DRUG

SC Methylnaltrexone (MNTX)

Dose 3

DRUG

IV Methylnaltrexone (MNTX)

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367496 - Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose | Biotech Hunter | Biotech Hunter